<SEC-DOCUMENT>0001513162-13-000271.txt : 20130408
<SEC-HEADER>0001513162-13-000271.hdr.sgml : 20130408
<ACCEPTANCE-DATETIME>20130408161930
ACCESSION NUMBER:		0001513162-13-000271
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20130402
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Termination of a Material Definitive Agreement
FILED AS OF DATE:		20130408
DATE AS OF CHANGE:		20130408

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BIOMERICA INC
		CENTRAL INDEX KEY:			0000073290
		STANDARD INDUSTRIAL CLASSIFICATION:	DENTAL EQUIPMENT & SUPPLIES [3843]
		IRS NUMBER:				952645573
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0531

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-08765
		FILM NUMBER:		13748603

	BUSINESS ADDRESS:	
		STREET 1:		17571 VON KARMAN AVENUE
		CITY:			IRVINE
		STATE:			CA
		ZIP:			92614
		BUSINESS PHONE:		9496452111

	MAIL ADDRESS:	
		STREET 1:		17571 VON KARMAN AVENUE
		CITY:			IRVINE
		STATE:			CA
		ZIP:			92614

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NMS PHARMACEUTICALS INC
		DATE OF NAME CHANGE:	19871130

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NUCLEAR MEDICAL SYSTEMS INC
		DATE OF NAME CHANGE:	19830216

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NUCLEAR INSTRUMENTS INC
		DATE OF NAME CHANGE:	19720508
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>biomerica8k4213final.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML>
<head><title>FORM 8-K</title> </head> <body style="MARGIN-TOP:0px; FONT-FAMILY:Times New Roman; COLOR:#000000; FONT-SIZE:10pt"> <p style="MARGIN:0px; FONT-SIZE:12pt" align=center>SECURITIES AND EXCHANGE COMMISSION</p> <p style=MARGIN:0px><br></p> <p style="MARGIN:0px; FONT-SIZE:12pt" align=center>WASHINGTON, D.C.</p> <p style=MARGIN:0px><br></p> <p style="MARGIN:0px; FONT-SIZE:12pt" align=center>FORM 8-K</p> <p style=MARGIN:0px><br></p> <p style="MARGIN:0px; FONT-SIZE:12pt" align=center>CURRENT REPORT</p> <p style=MARGIN:0px><br></p> <p style=MARGIN:0px><br></p> <p style="MARGIN:0px; FONT-SIZE:12pt" align=center>Pursuant to Section 13 or 15(d) of the</p> <p style="MARGIN:0px; FONT-SIZE:12pt" align=center>Securities Exchange Act of 1934</p> <p style=MARGIN:0px><br></p> <p style=MARGIN:0px><br></p> <p style="MARGIN:0px; FONT-SIZE:12pt" align=center><u>_____ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;April 2, 2013__________</u></p> <p style="MARGIN:0px; FONT-SIZE:12pt" align=center>Date of Report (date of earliest event reported)</p> <p style=MARGIN:0px align=center><br></p> <p style=MARGIN:0px align=center><br></p> <p style="MARGIN:0px; FONT-SIZE:12pt" align=center><u>BIOMERICA, INC.</u></p> <p style="MARGIN:0px; FONT-SIZE:12pt" align=center>(Exact Name of Registrant as Specified in its Charter)</p> <p style="MARGIN:0px; FONT-SIZE:12pt" align=center>&nbsp;</p> <p style="MARGIN:0px; FONT-SIZE:12pt" align=center> <table width=100% bordercolor=transparent style="WIDTH:100%; HEIGHT:0px" cellspacing=0> <tr> <td>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </td> <td align=center><u>Delaware</u></td> <td align=center></td> <td align=center><u>0-8765</u></td> <td> <td align=center><font style="FONT-FAMILY:'Times New Roman','serif'; FONT-SIZE:12pt"><u>95-2645573</u></font></td></tr> <tr> <td> <td align=center>(State or Other</td> <td align=center> <td align=center>(Commission</td> <td> <td align=center>(IRS Employer</td> </tr><tr> <td> <td align=center>Jurisdiction of</td> <td align=center> <td align=center>File Number)</td> <td> <td align=center>Identification Number)</td> <tr> <td> <td align=center>Incorporation)</td> <td align=center> <td align=center> <td> <td align=center /></tr></table></p> <p style=MARGIN:0px>&nbsp;</p> <p style="MARGIN:0px; FONT-SIZE:12pt" align=center>17571 Von Karman Ave.</p> <p style="MARGIN:0px; FONT-SIZE:12pt" align=center><u>Irvine, California 92614</u></p> <p style="MARGIN:0px; FONT-SIZE:12pt" align=center>(Address of Principal Executive Offices</p> <p style="MARGIN:0px; FONT-SIZE:12pt" align=center>Including Zip Code)</p> <p style=MARGIN:0px align=center><br></p> <p style=MARGIN:0px align=center><br></p> <p style="MARGIN:0px; FONT-SIZE:12pt" align=center><u>949-645-2111</u></p> <p style="MARGIN:0px; FONT-SIZE:12pt" align=center>(Registrant&#146;s Telephone Number,</p> <p style="MARGIN:0px; FONT-SIZE:12pt" align=center>Including Area Code)</p> <p style=MARGIN:0px align=center><br></p> <p style="MARGIN:0px; FONT-SIZE:12pt" align=center>______________</p> <p style="MARGIN:0px; FONT-SIZE:12pt" align=center>(Former Name or Former Address if Changed</p> <p style="MARGIN:0px; FONT-SIZE:12pt" align=center>Since Last Report)</p> <p style=MARGIN:0px align=center><br></p> <p style="MARGIN:0px; FONT-SIZE:12pt" align=center>Page 1 of 2 pages</p> <p style=MARGIN:0px align=center><br></p> <p style=MARGIN:0px align=center><br></p> <p style=MARGIN:0px align=center><br></p> <p style=MARGIN:0px align=center><br></p> <p margin:0px style=PAGE-BREAK-BEFORE:always align=center><br> <hr> <p /> <p style="MARGIN-TOP:0px; WIDTH:96px; MARGIN-BOTTOM:-2px; FLOAT:left; FONT-SIZE:12pt">Item 1.01. </p> <p style="TEXT-INDENT:-2px; MARGIN:0px; FONT-SIZE:12pt">Entry into a Material Definitive Agreement</p> <p style="MARGIN:0px; CLEAR:left"><br></p> <p style=MARGIN:0px><br></p> <p style="TEXT-INDENT:48px; MARGIN:0px; FONT-SIZE:12pt">On April 2, 2013, Biomerica, Inc. ("Biomerica" or the "Company") entered into a new exclusive distribution agreement and a First Amendment thereto with a new distributor in China (the &#147;New Distribution Agreement&#148;). The New Distribution Agreement has a three year term and covers the Company&#146;s GAD, ICA, IAA and certain food intolerance products for the China market. The terms of the New Distribution Agreement are similar to the former distribution agreement entered into with the Company&#146;s former China distributor which was terminated as described in Item 1.02 below (the &#147;Prior Distribution Agreement&#148;). &nbsp;The New Distribution Agreement provides for greater minimum sales volumes than were in the Company&#146;s Prior Distribution Agreement. </p> <p style=MARGIN:0px><br></p> <p style=MARGIN:0px><br></p> <p style="MARGIN-TOP:0px; WIDTH:96px; MARGIN-BOTTOM:-2px; FLOAT:left; FONT-SIZE:12pt">Item 1.02.</p> <p style="TEXT-INDENT:-2px; MARGIN:0px; FONT-SIZE:12pt">Termination of Material Definitive Agreement.</p> <p style="MARGIN:0px; CLEAR:left"><br></p> <p style="TEXT-INDENT:48px; MARGIN:0px; FONT-SIZE:12pt">On April 2, 2013, prior to entering into the New Distribution Agreement described in Item 1.01 above, the Company terminated its existing exclusive Prior Distribution Agreement with its distributor in China. At the time of the termination of the Prior Distribution Agreement, there was no accounts receivable due from the prior distributor<font style=COLOR:#00007f>.</font></p> <p style=MARGIN:0px align=center><br></p> <p style=MARGIN:0px align=center><br></p> <p style=MARGIN:0px align=center><br></p> <p style=MARGIN:0px><br></p> <p style=MARGIN:0px align=center><br></p> <p style=MARGIN:0px align=center><br></p> <p style=MARGIN:0px><br></p> <p style=MARGIN:0px align=center><br></p> <p style=MARGIN:0px align=center><br></p> <p style=MARGIN:0px align=center><br></p> <p style=MARGIN:0px align=center><br> <p /> <p style="MARGIN:0px; PADDING-RIGHT:28px; FONT-SIZE:12pt" align=center><u>SIGNATURES</u></p> <p style=MARGIN:0px><br></p> <p style="MARGIN:0px; PADDING-RIGHT:28px; FONT-SIZE:12pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p> <p style=MARGIN:0px><br></p> <p style="MARGIN-TOP:0px; WIDTH:288px; MARGIN-BOTTOM:-2px; FLOAT:left; FONT-SIZE:12pt">Dated: &nbsp;April 8, 2013</p> <p style="TEXT-INDENT:-2px; MARGIN:0px; PADDING-RIGHT:28px; FONT-SIZE:12pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Biomerica, Inc.</p> <p style="MARGIN:0px; CLEAR:left"><br></p> <p style="TEXT-INDENT:336px; MARGIN:0px; PADDING-RIGHT:28px; FONT-SIZE:12pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;By: <u>/s/ Zackary S. Irani</u></p> <p style="TEXT-INDENT:384px; MARGIN:0px; PADDING-RIGHT:28px; FONT-SIZE:12pt">Zackary S. Irani</p> <p style="TEXT-INDENT:384px; MARGIN:0px; PADDING-RIGHT:28px; FONT-SIZE:12pt">Chief Executive Officer</p> <p style=MARGIN:0px align=center><br></p> <p style=MARGIN:0px align=center><br></p> <p style=MARGIN:0px align=center><br><br></p></body>
<!-- EDGAR Validation Code: 1D8F1956 -->
</HTML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
